BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 34453381)

  • 21. Syngeneic graft-versus-host disease: a report of two cases and literature review.
    Latif T; Pohlman B; Kalaycio M; Sobecks R; Hsi ED; Andresen S; Bolwell BJ
    Bone Marrow Transplant; 2003 Sep; 32(5):535-9. PubMed ID: 12942102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Graft-vs.-host disease.
    Woo SB; Lee SJ; Schubert MM
    Crit Rev Oral Biol Med; 1997; 8(2):201-16. PubMed ID: 9167093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of severe refractory hepatic graft-versus-host disease by cadaveric liver transplant.
    Zeidan AM; Wozney JL; Torbenson M; Krok K; BolaƱos-Meade J
    Leuk Lymphoma; 2013 Dec; 54(12):2756-9. PubMed ID: 23517590
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological basis for treatment of graft versus host disease after liver transplant.
    Rai V; Dietz NE; Agrawal DK
    Expert Rev Clin Immunol; 2016; 12(5):583-93. PubMed ID: 26795873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathology of bone marrow transplantation.
    Bombi JA; Palou J; Bruguera M; Feliu E; Martin-Ortega E; Rozman C; Cardesa A
    Semin Diagn Pathol; 1992 Aug; 9(3):220-31. PubMed ID: 1523360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide in the treatment of graft-versus-host disease.
    Heney D; Bailey CC; Lewis IJ
    Biomed Pharmacother; 1990; 44(4):199-204. PubMed ID: 2204450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft-versus-host disease.
    Parkman R
    Annu Rev Med; 1991; 42():189-97. PubMed ID: 2035965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graft-versus-host disease in allogeneic bone marrow transplantation: the role of monoclonal antibodies in prevention and treatment.
    Hiscott A; McLellan DS
    Br J Biomed Sci; 2000; 57(2):163-9. PubMed ID: 10912294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition, incidence, and management of oral graft-versus-host disease.
    Schubert MM; Sullivan KM
    NCI Monogr; 1990; (9):135-43. PubMed ID: 2188151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.
    Champlin R; Giralt S; Gajewski J
    Acta Haematol; 1996; 95(3-4):157-63. PubMed ID: 8677736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data.
    Barshes NR; Myers GD; Lee D; Karpen SJ; Lee TC; Patel AJ; Finegold M; Goss JA
    Liver Transpl; 2005 May; 11(5):525-31. PubMed ID: 15838886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grading acute graft-versus-host disease: time to reconsider.
    Goyal RK; Goyal M; Sankaranarayan K
    Pediatr Transplant; 2015 May; 19(3):252-4. PubMed ID: 25599820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental and clinical gnotobiotics: influence of the microflora on graft-versus-host disease after allogeneic bone marrow transplantation.
    Heidt PJ; Vossen JM
    J Med; 1992; 23(3-4):161-73. PubMed ID: 1479298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
    Schwinghammer TL; Bloom EJ
    Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation.
    Murphy WJ; Longo DL
    Immunol Rev; 1997 Jun; 157():167-76. PubMed ID: 9255629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemophagocytic syndrome with graft-versus-host disease after liver transplantation: The bone marrow as a not so quiet battlefield?
    Szabolcs P
    Am J Transplant; 2021 Dec; 21(12):3823-3824. PubMed ID: 34453381
    [No Abstract]   [Full Text] [Related]  

  • 37. Ocular graft-versus-host disease: a review.
    Shikari H; Antin JH; Dana R
    Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease.
    Chien YH; Lin KH; Lee TY; Lu MY; Tsau YK
    J Formos Med Assoc; 2000 Jun; 99(6):503-6. PubMed ID: 10925558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graft versus host disease following allogeneic bone marrow transplantation.
    Chao NJ
    Curr Opin Immunol; 1992 Oct; 4(5):571-6. PubMed ID: 1418721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute graft versus host disease after orthotopic liver transplantation.
    Rogulj IM; Deeg J; Lee SJ
    J Hematol Oncol; 2012 Aug; 5():50. PubMed ID: 22889203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.